204 related articles for article (PubMed ID: 21908384)
1. Mycobacterium chelonae infection involving the auricle.
Lin YH; Liu TC
QJM; 2012 Oct; 105(10):1021-2. PubMed ID: 21908384
[No Abstract] [Full Text] [Related]
2. Topical linezolid for refractory bilateral Mycobacterium chelonae post-laser-assisted in situ keratomileusis keratitis.
Dolz-Marco R; Udaondo P; Gallego-Pinazo R; Millán JM; Díaz-Llopis M
Arch Ophthalmol; 2012 Nov; 130(11):1475-6. PubMed ID: 23143454
[No Abstract] [Full Text] [Related]
3. Dissemination of a localized cutaneous infection with Mycobacterium chelonae under immunosuppressive treatment.
Hoetzenecker W; Ulmer A; Klingel K; Kempf VA; Schanz S; Metzler G; Fierlbeck G
Arch Dermatol; 2007 Jul; 143(7):951-2. PubMed ID: 17638751
[No Abstract] [Full Text] [Related]
4. [Development of subcutaneous nodules after mesotherapy].
Ramos A; Roustan G; Lucena JL; Daza RM
Enferm Infecc Microbiol Clin; 2011 Dec; 29(10):775-7. PubMed ID: 21722998
[No Abstract] [Full Text] [Related]
5. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient.
Tebas P; Sultan F; Wallace RJ; Fraser V
Clin Infect Dis; 1995 Feb; 20(2):443-4. PubMed ID: 7742453
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium chelonae (M. chelonae subspecies chelonae): report of a patient with a sporotrichoid presentation who was successfully treated with clarithromycin and ciprofloxacin.
Zahid MA; Klotz SA; Goldstein E; Bartholomew W
Clin Infect Dis; 1994 Jun; 18(6):999-1001. PubMed ID: 8086568
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous Mycobacterium chelonae infection presenting as symmetrical plaques on both shins in an immunocompetent patient.
Chung WK; Kim MS; Kim CH; Lee MW; Choi JH; Moon KC; Koh JK
Acta Derm Venereol; 2009 Nov; 89(6):663-4. PubMed ID: 19997711
[No Abstract] [Full Text] [Related]
8. Atypical mycobacteria keratitis after laser in situ keratomileusis unresponsive to fourth-generation fluoroquinolone therapy.
de la Cruz J; Behlau I; Pineda R
J Cataract Refract Surg; 2007 Jul; 33(7):1318-21. PubMed ID: 17586393
[TBL] [Abstract][Full Text] [Related]
9. Induction therapy with linezolid/clarithromycin combination for Mycobacterium chelonae skin infections in immunocompromised hosts.
Parize P; Hamelin A; Veziris N; Morand PC; Guillemain R; Lortholary O; Dupin N
J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):101-5. PubMed ID: 25677464
[TBL] [Abstract][Full Text] [Related]
10. Maximum growth temperature test for cutaneous Mycobacterium chelonae predicts the efficacy of thermal therapy.
Ota R; Iwasawa MT; Ohkusu K; Kambe N; Matsue H
J Dermatol; 2012 Feb; 39(2):205-6. PubMed ID: 21767294
[No Abstract] [Full Text] [Related]
11. Molecular diagnosis of a Mycobacterium chelonae infection.
Schulz S; Kremer M; Cabras AD; Lügering A; Seidel M; Höfler H; Werner M
Pathol Res Pract; 2001; 197(2):123-6; discussion 127-8. PubMed ID: 11261816
[TBL] [Abstract][Full Text] [Related]
12. An outbreak of cutaneous infection due to Mycobacterium abscessus associated to mesotherapy.
Galmés-Truyols A; Giménez-Duran J; Bosch-Isabel C; Nicolau-Riutort A; Vanrell-Berga J; Portell-Arbona M; Seguí-Prat B; Gumá-Torá M; Martí-Alomar I; Rojo-Arias MÁ; Ruiz-Veramendi M
Enferm Infecc Microbiol Clin; 2011; 29(7):510-4. PubMed ID: 21684045
[TBL] [Abstract][Full Text] [Related]
13. In vitro bactericidal activity of antibiotic combinations against clinical isolates of Mycobacterium chelonae.
Cremades R; Santos A; Rodríguez JC; Garcia-Pachon E; Ruiz M; Royo G
J Chemother; 2008 Feb; 20(1):43-7. PubMed ID: 18343742
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium chelonae infection successfully treated with oral clarithromycin and linezolid.
Kyle SD; Porter WM
Br J Dermatol; 2004 Nov; 151(5):1101. PubMed ID: 15541095
[No Abstract] [Full Text] [Related]
15. Outbreak of mesotherapy-associated cutaneous infections caused by Mycobacterium chelonae in Colombia.
Correa NE; Cataño JC; Mejía GI; Realpe T; Orozco B; Estrada S; Vélez A; Vélez L; Barón P; Guzmán A; Robledo J
Jpn J Infect Dis; 2010 Mar; 63(2):143-5. PubMed ID: 20332582
[No Abstract] [Full Text] [Related]
16. Cutaneous Mycobacterium chelonae infection in a rheumatoid arthritis patient treated with etanercept.
Hamaguchi Y; Fujimoto M; Oishi K; Kitajima S; Wada T; Takehara K
Eur J Dermatol; 2013; 23(5):700-1. PubMed ID: 24135619
[No Abstract] [Full Text] [Related]
17. Skin and Soft Tissue Infections Caused by Mycobacterium chelonae: More Common Than Expected?
Uslu U; Böhm O; Heppt F; Sticherling M
Acta Derm Venereol; 2019 Sep; 99(10):889-893. PubMed ID: 31141157
[TBL] [Abstract][Full Text] [Related]
18. Periodic fever and skin lesions caused by disseminated Mycobacterium chelonae infection in an immunocompetent child.
Ryan ME; Ferrigno K; O'Boyle T; Long SS
Pediatr Infect Dis J; 1996 Mar; 15(3):270-2. PubMed ID: 8852921
[No Abstract] [Full Text] [Related]
19. Disseminated Mycobacterium chelonae Infection Identified by Repeated Skin Sampling and Molecular Methods in a Patient with Rheumatoid Arthritis.
Tsutsumi R; Yamada N; Yoshida Y; Nakanaga K; Ishii N; Yamamoto O
Acta Derm Venereol; 2016 Jan; 96(1):132-3. PubMed ID: 26122695
[No Abstract] [Full Text] [Related]
20. Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection.
Driscoll MS; Tyring SK
J Am Acad Dermatol; 1997 Mar; 36(3 Pt 1):495-6. PubMed ID: 9091495
[No Abstract] [Full Text] [Related]
[Next] [New Search]
